The broader market's historic rebound may make it necessary to consider some defensive positions in the portfolio, and these ...

Analysts expect Johnson & Johnson to report an earnings per share (EPS) of $2.67. Johnson & Johnson bulls will hope to hear ...

Dividend stocks have historically outperformed non-dividend payers. Dividend stocks can make great long-term investments.

“The Board’s strategic review is underway, and we are considering a broad range of potential alternatives, including ways to ...

Historically, Johnson & Johnson has been a fairly stable stock to own. Johnson & Johnson (NYSE: JNJ) has been a leading ...

Telos Capital Management reduced its Johnson & Johnson stake by nearly 11% last quarter, selling 5,837 shares worth over $8 ...

According to a July 10, 2025 SEC filing, the firm exited its entire position in Johnson & Johnson during Q2 2025, selling all ...

Which is the best dividend aristocrat to buy in 2020? A dividend stock battle of consumer goods and healthcare giants!

The upcoming week marks the beginning of earnings season, with a lineup of heavyweights across banking, healthcare, tech, and industrials. Big banks lead the charge with reports from JPMorgan Chase ...

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

Parr Mcknight Wealth Management Group trimmed its Johnson & Johnson holdings by 4.6% this quarter, selling 2,528 shares while ...